Cargando…
Discovery of a Chemical Modification by Citric Acid in a Recombinant Monoclonal Antibody
[Image: see text] Recombinant therapeutic monoclonal antibodies exhibit a high degree of heterogeneity that can arise from various post-translational modifications. The formulation for a protein product is to maintain a specific pH and to minimize further modifications. Generally Recognized as Safe...
Autores principales: | Chumsae, Chris, Zhou, Liqiang Lisa, Shen, Yang, Wohlgemuth, Jessica, Fung, Emma, Burton, Randall, Radziejewski, Czeslaw, Zhou, Zhaohui Sunny |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American
Chemical
Society
2014
|
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4165448/ https://www.ncbi.nlm.nih.gov/pubmed/25136741 http://dx.doi.org/10.1021/ac502179m |
Ejemplares similares
-
Discovery of a second citric acid cycle complex
por: Roosterman, Dirk, et al.
Publicado: (2023) -
Simple rapid stabilization method through citric acid modification for magnetite nanoparticles
por: Dheyab, Mohammed Ali, et al.
Publicado: (2020) -
Demineralization, Collagen Modification and Remineralization Degree of Human Dentin after EDTA and Citric Acid Treatments
por: Gandolfi, Maria Giovanna, et al.
Publicado: (2018) -
Biotechnological production of citric acid
por: Max, Belén, et al.
Publicado: (2010) -
Dr. Trotter, on Citric Acid
por: Trotter, T.
Publicado: (1800)